I just read the Strong Bio article on Stinking-Alp
Post# of 72440
Quote:
Cellceutix owns the rights to various drug compounds, including Kevetrin (thioureidobutyronitrile), which is its anti-(ovarian) cancer compound; Prurisol (KM-133) which is in development for psoriasis, and Brilacidin, which is its drug in a class of compounds known as defensin-mimetics or antibiotic.
Quote:
According to the company website, Brilacidin and Prurisol are well into phase 2 and Kevetrin, a p53 enhancer, is well into phase 1.
All in all I agree it is a bit of a soft-bashing piece, but not as one sided as most of the others we see on Sucking Alpha. The author took pains to appear as objective and emotionally disengaged as possible, but the overall tone of the article was one of caution and, a not-quite-yet investment sentiment. Why do these fuckers always post from an alias? That, in and of itself, makes me wary of their true intentions!